iCellate
iCellate is a Swedish research and development company focused on cancer research and detection products.
iCellate has raised €4.6M across 2 funding rounds, most recently a round in Feb 2021. Based in Stockholm, Sweden; founded 2011; active in Healthtech. Data as of 28 Oct 2026.
Total raised
€4.6M
€4,600,000
Funding rounds
2
Investors
0
distinct backers
Active since
2019-10
latest 2021-02
Funding by year
EUR raised per yeariCellate — funding by year — interactive chart.
Data table
| iCellate — funding by year | |
|---|---|
| 2019 | €2.2M |
| 2021 | €2.4M |
Signals
Medium confidenceRaise-next likelihood6
base rate 30% for Other
- ▼ Dormant (no round in 3+ cohort gaps)
Exit likelihood6
base rate 11% (2+ rounds)
- ▼ No recent equity round (debt-only or quiet)
Timing: dormant vs cohort gap · momentum flat. Funding-only estimates, not predictions and not investment advice — see signals.
Funding rounds
2 rounds| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2021-02-10 | Other | €2.4M | — | View deal → |
| 2019-10-01 | Series D+ | €2.2M | — | View deal → |
Similar companies
same sector or countryGlobal coverage: FundingData